SCM
MRTX

Sio Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Sio Capital Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,451,925
Closed -$85.3M – 62
2023
Q4 		$85.3M Buy
+1,451,925
New +$81.6M 19.42% 1
2019
Q4 		– Sell
-96,525
Closed -$7.52M – 89
2019
Q3 		$7.52M Sell
96,525
-38,775
-29% -$3.64M 2.42% 13
2019
Q2 		$13.9M Buy
135,300
+78,500
+138% +$6.11M 3.36% 6
2019
Q1 		$4.16M Buy
+56,800
New +$3.86M 1.12% 34
2018
Q3 		– Sell
-60,050
Closed -$2.96M – 79
2018
Q2 		$2.96M Buy
+60,050
New +$2.27M 1.64% 25
2015
Q4 		– Sell
-57,605
Closed -$1.98M – 49
2015
Q3 		$1.98M Buy
57,605
+49,597
+619% +$1.5M 1.36% 23
2015
Q2 		$252K Sell
8,008
-38,669
-83% -$1.14M 0.12% 38
2015
Q1 		$1.37M Buy
+46,677
New +$1.09M 0.78% 24

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sio Capital Management's MRTX Position: Q1 2024 in Review

Sio Capital Management sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 1,451,925 shares — an estimated $85.3M sold.

Sio Capital Management first reported a position in MRTX in Q1 2015 and held it in 8 quarters. The position peaked at $85.3M in Q4 2023. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • Sio Capital Management reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Sio Capital Management sold 1,451,925 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $85.3M.
  • Sio Capital Management first reported a position in Mirati Therapeutics, Inc. Common Stock in Q1 2015 and held it in 8 quarters.
  • Sio Capital Management's Mirati Therapeutics, Inc. Common Stock position peaked at $85.3M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Sio Capital Management's 13F filing for Q1 2024, filed 15 May 2024.